Trials / Unknown
UnknownNCT01402726
Renal Sympathetic Modification in Patients With Heart Failure
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to observe the incident of composite cardiovascular events after renal sympathetic modification using THERMOCOOL® catheter in patients with heart failure, and evaluate safety and efficacy of the intervention.
Detailed description
Heart failure is a clinical syndrome of chronic cardiac dysfunction, with high morbidity and mortality. Traditional pharmacological therapies are used in clinical practice without breakthrough for long time. Previous studies confirmed that partly blocking sympathetic nerves activity contributed to improve cardiac function in patients with heart failure. Renal ablation with sympathetic modification is a new method which is proved to be effective in decreasing sympathetic nerves activity. The investigators hypothesis that renal sympathetic nerves modification is effective and safe in improving cardiac function. This trial is going to recruit 200 patients (Ablation group VS Control group = 1:1) with a follow-up duration of 3 years. Patients in ablation group will receive additional necessary anti-heart failure drugs besides expectant intervention, and patients in control group will receive appropriate anti-heart failure drugs only. The investigators aim to observe the incident of composite cardiovascular events after renal sympathetic modification using THERMOCOOL® catheter in patients with heart failure, and evaluate safety and efficacy of the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | renal sympathetic modification | Device: THERMOCOOL® Catheter Renal sympathetic modification with a catheter-based procedure |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2019-12-01
- Completion
- 2020-06-01
- First posted
- 2011-07-26
- Last updated
- 2019-03-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01402726. Inclusion in this directory is not an endorsement.